FINN (CA209-7MA): A non-interventional study (NIS) of first-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in metastatic non-small cell lung cancer
ONCOLOGY RESEARCH AND TREATMENT（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要